Moleculin Biotech, Inc. Annual Operating Income (Loss) in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Moleculin Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2024.
  • Moleculin Biotech, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$6.64M, a 25.5% increase year-over-year.
  • Moleculin Biotech, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$26.6M, a 10.1% increase year-over-year.
  • Moleculin Biotech, Inc. annual Operating Income (Loss) for 2024 was -$26.6M, a 10.1% increase from 2023.
  • Moleculin Biotech, Inc. annual Operating Income (Loss) for 2023 was -$29.6M, a 3.29% increase from 2022.
  • Moleculin Biotech, Inc. annual Operating Income (Loss) for 2022 was -$30.6M, a 33.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$26.6M +$2.99M +10.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-21
2023 -$29.6M +$1.01M +3.29% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-21
2022 -$30.6M -$7.67M -33.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 -$23M -$3.23M -16.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$19.7M -$2.22M -12.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$17.5M -$2.5M -16.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 -$15M -$6.37M -73.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 -$8.65M -$4.77M -123% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-21
2016 -$3.88M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.